“…(À)-Physostigmine (Scheme 1), 1 initially isolated from the seeds of Physostigma venenosum in 1864, 2,3 has been clinically used for the treatment of glaucoma, myasthenia gravis, atropine, and organophosphate intoxication, and for the relief of intoxication induced by overdoses of antidepressants, antihistamines, antipsychotics, and benzodiazepines. 1,4-6 (À)-Physostigmine is a potent inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), thereby showing wide biological activities.…”